Previously, we showed that SETD8 is overexpressed in NB cells compared to normal cells, and elevated SETD8 significantly correlates with poor prognosis in NB primary tumors, particularly the MYCN-WT subset [11]. This evidence concerns the gene KMT5A and neuroblastoma.